Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 104.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 10,813
  • Market Cap: £88.07m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
48.69% above the market average48.69% above the market average48.69% above the market average48.69% above the market average48.69% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
1yr Revenue Growth
63.27% above the market average63.27% above the market average63.27% above the market average63.27% above the market average63.27% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
21.76% above the market average21.76% above the market average21.76% above the market average21.76% above the market average21.76% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Book Ratio
46.56% below the market average46.56% below the market average46.56% below the market average46.56% below the market average46.56% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
34.76% above the market average34.76% above the market average34.76% above the market average34.76% above the market average34.76% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Price Chg 3m
77.46% above the market average77.46% above the market average77.46% above the market average77.46% above the market average77.46% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
42.44% above the market average42.44% above the market average42.44% above the market average42.44% above the market average42.44% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Momentum 20
39.68% above the market average39.68% above the market average39.68% above the market average39.68% above the market average39.68% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
22.87% below the market average22.87% below the market average22.87% below the market average22.87% below the market average22.87% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
ROCE
77.1% below the market average77.1% below the market average77.1% below the market average77.1% below the market average77.1% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.54% below the market average12.54% below the market average12.54% below the market average12.54% below the market average12.54% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
25.36% below the market average25.36% below the market average25.36% below the market average25.36% below the market average25.36% below the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average
Operating Profit Loss
9.68% below the market average9.68% below the market average9.68% below the market average9.68% below the market average9.68% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
6.34% above the market average6.34% above the market average6.34% above the market average6.34% above the market average6.34% above the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Cash
29.08% above the market average29.08% above the market average29.08% above the market average29.08% above the market average29.08% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
67.66% above the market average67.66% above the market average67.66% above the market average67.66% above the market average67.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
13.95% below the market average13.95% below the market average13.95% below the market average13.95% below the market average13.95% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 104.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 109.00
52 Week Low 80.50
Volume 10,813
Shares Issued 84.68m
Market Cap £88.07m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.72% below the market average90.72% below the market average90.72% below the market average90.72% below the market average90.72% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Price Trend
40.21% above the market average40.21% above the market average40.21% above the market average40.21% above the market average40.21% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average
Income Not Available
Growth
3.13% above the market average3.13% above the market average3.13% above the market average3.13% above the market average3.13% above the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average

Diaceutics Dividends

No dividends found

Trades for 12-Apr-2024

Time Volume / Share Price
15:54 500 @ 104.20p
14:25 6,736 @ 103.81p
11:47 2,867 @ 104.20p
10:04 239 @ 104.20p
08:03 470 @ 103.70p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page